J4E-28949-48562
4 vaccinations
3 coded responses
46 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 620 / IL
- Registered
- 2021-03-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-07
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-09
Registered in v-safe
-
2021-03-09
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-03-11
- 2021-03-12
- 2021-03-13
-
2021-03-14
Survey response — day 7, dose 1MedDRA: Unevaluable event — Feeling: GoodFree text: ReliefMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-21
- 2021-03-28
- 2021-04-04
- 2021-04-11
- 2021-04-19
- 2021-06-06
-
2021-09-05
Survey response — 6 months, dose 1MedDRA: Nephrolithiasis — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Kidney stone but dr thinks stress relatedMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-05
Report sent to call center — 6 months, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-09-09
Call successfulDoes not wish to fill out VAERS report
-
2021-10-22
Dose 2 — Moderna
- 2021-10-22
-
2021-10-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-25
- 2021-10-27
- 2021-10-28
- 2021-10-29
- 2021-11-05
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2022-01-21
- 2022-04-22
-
2022-05-13
Dose 3 — Moderna
-
2022-05-14
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-05-15
- 2022-05-16
- 2022-05-18
- 2022-05-19
- 2022-05-20
- 2022-05-27
- 2022-06-03
- 2022-06-10
- 2022-06-17
- 2022-06-24
- 2022-08-12
-
2022-09-14
Dose 4 — Pfizer-BioNTech
-
2022-09-25
Survey response — day 7, dose 4MedDRA: Postpartum state — Feeling: GoodFree text: Was 6 weeks postpartum when receivedMedDRA releases: 2024-11 · check-in free text available
- 2022-09-28
- 2022-10-05
- 2022-10-14
- 2022-10-21
- 2022-10-26
- 2022-12-16
- 2023-03-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-07 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-22 | Moderna | No |
| 3 | 2022-05-13 | Moderna | No |
| 4 | 2022-09-14 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 5 — day 7, dose 1
Systemic reaction (other): Relief
Release 9 — 6 months, dose 1
Symptoms: Kidney stone but dr thinks stress related
Release 12 — day 7, dose 4
Systemic reaction (other): Was 6 weeks postpartum when received
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nephrolithiasis | ✓ | · | ✓ |
| SRO | Postpartum state | · | · | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release